Innospec (IOSP) Common Equity (2010 - 2026)

Innospec's Common Equity history runs 17 years deep, the most recent figure standing at $1.3 billion for Q1 2026.

• In Q1 2026, Common Equity rose 6.27% year-over-year to $1.3 billion; the TTM figure through Mar 2026 stood at $1.3 billion (up 6.27% YoY), while the FY2025 annual figure was $1.3 billion, up 9.05% from the prior year.
• Common Equity came in at $1.3 billion for Q1 2026 at Innospec, up from $1.3 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $1.3 billion in Q1 2026 to a low of $1.0 billion in Q4 2022.
• A 5-year average of $1.2 billion and a median of $1.2 billion in 2024 frame the typical range for Common Equity.
• On a YoY basis, Common Equity climbed as much as 11.45% in 2022 and fell as far as 0.72% in 2022.
• Innospec's Common Equity stood at $1.0 billion in 2022, then climbed by 10.5% to $1.1 billion in 2023, then climbed by 5.78% to $1.2 billion in 2024, then grew by 9.05% to $1.3 billion in 2025, then climbed by 1.43% to $1.3 billion in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $1.3 billion, $1.3 billion, and $1.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison